Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$4.78
+0.0800 (+1.70%)
At Close: May 09, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $4.28 $5.69 Thursday, 9th May 2024 MBRX stock ended at $4.78. This is 1.70% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 9.54% from a day low at $4.61 to a day high of $5.05.
90 days $0.400 $6.23
52 weeks $0.338 $6.23

Historical Moleculin Biotech Inc prices

Date Open High Low Close Volume
Nov 08, 2023 $0.583 $0.591 $0.527 $0.555 20 422
Nov 07, 2023 $0.570 $0.588 $0.555 $0.555 69 227
Nov 06, 2023 $0.514 $0.599 $0.514 $0.588 142 582
Nov 03, 2023 $0.521 $0.530 $0.480 $0.511 51 223
Nov 02, 2023 $0.510 $0.527 $0.471 $0.510 24 827
Nov 01, 2023 $0.461 $0.500 $0.461 $0.482 39 302
Oct 31, 2023 $0.471 $0.510 $0.450 $0.475 125 358
Oct 30, 2023 $0.466 $0.508 $0.450 $0.454 153 112
Oct 27, 2023 $0.471 $0.515 $0.471 $0.480 108 262
Oct 26, 2023 $0.489 $0.510 $0.463 $0.488 69 687
Oct 25, 2023 $0.512 $0.550 $0.456 $0.468 77 002
Oct 24, 2023 $0.476 $0.520 $0.476 $0.490 125 026
Oct 23, 2023 $0.578 $0.589 $0.515 $0.521 121 074
Oct 20, 2023 $0.630 $0.630 $0.560 $0.590 125 644
Oct 19, 2023 $0.600 $0.665 $0.600 $0.615 131 834
Oct 18, 2023 $0.704 $0.704 $0.550 $0.585 325 377
Oct 17, 2023 $0.520 $0.740 $0.515 $0.609 1 967 571
Oct 16, 2023 $0.458 $0.530 $0.455 $0.490 238 984
Oct 13, 2023 $0.400 $0.458 $0.400 $0.450 107 111
Oct 12, 2023 $0.454 $0.477 $0.398 $0.406 102 928
Oct 11, 2023 $0.422 $0.480 $0.420 $0.454 19 846
Oct 10, 2023 $0.432 $0.497 $0.430 $0.430 66 154
Oct 09, 2023 $0.536 $0.536 $0.452 $0.459 71 768
Oct 06, 2023 $0.534 $0.534 $0.485 $0.500 75 767
Oct 05, 2023 $0.450 $0.520 $0.440 $0.490 183 482
Click to get the best stock tips daily for free!

About Moleculin Biotech Inc

Moleculin Biotech Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs. The company's flagship immune/transcription modulator is WP1066, which is in Phase I clinical trial fo... MBRX Profile

Golden Star

Ticker Date Change Price
PAG May 07 1.87% $153.22
WMT May 06 0.95% $59.87
UNP May 06 3.09% $239.21
JPM May 06 2.86% $192.00
ASH May 03 2.10% $95.85
INVH May 03 1.72% $34.39
INGR May 03 4.72% $114.56
VCSH May 03 0.0260% $76.93
BNDX May 03 0.205% $48.68
BBCA May 03 1.93% $65.44
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT